Table 3.
Characteristics | High risk (N = 150) | Low risk (N = 150) | Total (N = 300) | p value | |
---|---|---|---|---|---|
Age | <65 | 87 | 74 | 161 | 0.1647 |
≥65 | 63 | 76 | 139 | ||
Stage | Stage I | 9 | 21 | 30 | 0.0073 |
Stage II | 40 | 56 | 96 | ||
Stage III | 55 | 40 | 95 | ||
Stage IV | 45 | 32 | 77 | ||
NA | 1 | 1 | 2 | ||
T | T2 | 75 | 111 | 186 | <0.0001 |
T3 | 60 | 31 | 91 | ||
T4 | 14 | 7 | 21 | ||
NA | 1 | 1 | 2 | ||
M | M0 | 131 | 142 | 273 | 0.0437 |
M1 | 19 | 8 | 27 | ||
N | N0 | 14 | 24 | 38 | 0.1309 |
N1 | 62 | 69 | 131 | ||
N2 | 47 | 33 | 80 | ||
N3 | 27 | 24 | 51 | ||
Gender | Female | 53 | 48 | 101 | 0.6251 |
Male | 97 | 102 | 199 |